Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3707741
Reference Type
Journal Article
Title
Reactivity control in iron(III) amino triphenolate complexes: comparison of monomeric and dimeric complexes
Author(s)
Whiteoak, CJ; Gjoka, B; Martin, E; Belmonte, MM; Escudero-Adán, EC; Zonta, C; Licini, G; Kleij, AW
Year
2012
Is Peer Reviewed?
Yes
Journal
Inorganic Chemistry
ISSN:
0020-1669
EISSN:
1520-510X
Volume
51
Issue
20
Page Numbers
10639-10649
Language
English
PMID
23005255
DOI
10.1021/ic3008624
Web of Science Id
WOS:000309739100021
Abstract
Iron(III) amino triphenolate complexes with different substituents in the ortho-position of the phenolate moiety (R = H, Me, tBu, or Ph) have been synthesized by the reaction of iron(III) chloride and the sodium salt (Na(3)L(R)) of the requisite ligand. The complexes have been shown to be of either monomeric ([FeL(R)(THF)]) or dimeric ([FeL(R)](2)) nature by a combination of X-ray diffraction, (1)H NMR, solution magnetic susceptibility, and cyclic voltammetry studies. These analytical studies have shown that the monomeric and dimeric [FeL(R)] complexes behave distinctively, and that the dimer stability is a function of the ortho-positioned groups. Both the dimeric as well as monomeric complexes were tested as catalysts for the catalytic cycloaddition of carbon dioxide to oxiranes, and the data show that the monomeric complexes are able to mediate this conversion with significantly higher activities than the dimeric complexes. This difference in reactivity is controlled by the substitution pattern on the ligand L(R), and is in line with the catalytic requisite of binding of the epoxide substrate by the iron(III) center.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity